Plus, Pfizer announced it is initiating a program to screen antiviral drugs in its pipeline to identify possible treatments for the coronavirus, Target and Kohl’s reported earnings, and Thermo Fisher is buying Qiagen.
Read MoreBuy Target – $11.00 or better Sell Target – TradersPro Sell Signal Kindred Biosciences, Inc., a commercial-stage biopharmaceutical company, focusing on developing therapies for pets. Its product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. The company offers Mirataz, a mirtazapine transdermal ointment for the management […]
Read MorePlus, Home Depot and Macy’s topped earnings estimates, while Shake Shack disappointed.
Read MoreOne analyst says this small diagnostics firm has demonstrated its ability and is now a Buy.
Read MoreTrade Setup Buy Target $59.48 Sell Target $65.02 CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a revolutionary gene editing technology that allows for precise directed changes to genomic DNA. It […]
Read MorePlus, the coronavirus finally has a name, Carnival Cruise Line said that the virus outbreak could dent full-year earnings, and Nissan is suing former Chairman Carlos Ghosn.
Read MoreTrade Setup Buy Target $2.48 Sell Target $3.04 DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers […]
Read MorePlus, there are now 8,200 confirmed cases of the Chinese coronavirus, Facebook reported a 51% rise in expenses, and GM said it’s bringing back the Hummer.
Read MorePlus, Johnson & Johnson’s chief scientific officer said he believes the company can develop a vaccine for the deadly virus within the next couple of months, and GM announced it’s investing $3 billion on the production of electric vehicles.
Read MoreBuy Target – $4.00 or better Sell Target – TradersPro Sell Signal Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, Diazoxide Choline Controlled Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a […]
Read MoreBuy Target – $46.50 or better Sell Target – TradersPro Sell Signal Forty Seven, Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of […]
Read MorePlus, mortgage applications surged in the first week of the year, Goldman Sachs delivered an earnings beat, and Target’s holiday sales disappointed.
Read MorePlus, the U.S. just slapped new sanctions on Iran, the Labor Department’s December jobs report disappointed, and Six Flags received two downgrades from the same analyst in less than 24 hours.
Read MorePlus, businesses added 202,000 jobs in December, a Boeing plan crashed in Iran killing 176, and Macy’s is reportedly closing 29 stores.
Read MorePlus, new details are emerging on the phase one trade deal between the U.S. and China, Boeing is officially halting production of the 737 Max, and Fiat Chrysler and Peugeot might be about to finalize a memorandum of understanding to merge.
Read More